SARCLISA ESCENA FDA approval date

The FDA approved SARCLISA ESCENA on 9 Jul 2026.

FDA approval date
9 Jul 2026

Drug identity has not yet been verified against registry records

Also recorded as ISATUXIMAB-IRFC

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-07-09DaySARCLISA ESCENAFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761445", "applicant_as_listed_by_fda": "SANOFI-AVENTIS U.S. LLC", "brand_names": ["SARCLISA ESCENA"], "active_ingredients": ["ISATUXIMAB-IRFC"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260709", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026